Genexine is focused on the development and commercialization of immunotherapeutics and next generation novel long-acting biologics.
Business Model:
Revenue: $9.4M
Employees: 51-200
Address: 700 Daewangpangyo-ro, Korea Bio Park Building B
City: Gyeonggi-do
State: gyeonggido
Zip: 13488
Country: KR
Genexine is focused on the development and commercialization of immunotherapeutics and next generation novel long-acting biologics.
Contact Phone:
Contact Email:
Listed Exchange:
Korea Exchange
Ticker Symbol:
095700
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2020 | ToolGen | Corporate Round | - |
3/2017 | I-Mab Biopharma | Series B | 0 |
12/2020 | ToolGen | Corporate Round | - |
3/2017 | I-Mab Biopharma | Series B | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2016 | Equity | $70M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|